Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s406483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Mingsheng Lyu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Respiratory Disease, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Asthma, Drugs, Chinese Herbal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Tuo-Min-Ding-Chuan Decoction (TMDCD) is an effective traditional Chinese medicine (TCM) formula granule for allergic asthma (AA). Previous studies proved its effects on controlling airway inflammations, while the specific mechanism was not clear.
Methods
We conducted a network pharmacology study to explore the molecular mechanism of TMDCD against AA with the public databases of TCMSP. Then, HUB genes were screened with the STRING database. DAVID database performed GO annotation and KEGG functional enrichment analysis of HUB genes, and it was verified with molecular docking by Autodock. Then, we built a classic ovalbumin-induced allergic asthma mice model to explore the mechanism of anti-inflammation effects of TMDCD.
Results
In the network pharmacology study, we found out that the potential mechanism of TMDCD against AA might be related to NOD-like receptor (NLR) signaling pathway and Toll-like receptor (TLR) signaling pathway. In the experiment, TMDCD showed remarkable effects on alleviating airway inflammations, airway hyperresponsiveness (AHR), and airway remodeling in the asthmatic mice model. Further molecular biology and immunohistochemistry experiments suggested TMDCD could repress TLR4-NLRP3 pathway-mediated pyroptosis-related gene transcriptions to inhibit expressions of target proteins.
Conclusion
TMDCD could alleviate asthmatic mice model airway inflammations by regulating TLR4-NLRP3 pathway-mediated pyroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Respiratory Disease, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
- Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
- Department of Geratology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
- Department of Infectious Disease, Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine, Beijing, People's Republic of China.
- College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
- National Institute of Traditional Chinese Medicine (TCM) Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
ORCID-Profile: Mingsheng Lyu, Jingbo Qin, Fan Yang, Xuefeng Gong, Ji Wang
Zitieren
APA
Lyu, M., Qin, J., Huang, S., Shao, D., Huang, G., Yang, F., Gong, X., Zhang, S., Zhang, Z., Wang, J., & Cui, H. (2023). Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s406483
Vancouver
Lyu M, Qin J, Huang S, Shao D, Huang G, Yang F, et al. Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s406483
BibTeX
@article{Lyu2023,
author = {Lyu, Mingsheng and Qin, Jingbo and Huang, Shuaiyang and Shao, Dongmei and Huang, Guirui and Yang, Fan and Gong, Xuefeng and Zhang, Shiyu and Zhang, Zhijie and Wang, Ji and Cui, Hongsheng},
title = {Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s406483}
}
EUVIMED